Volatility presents opportunities in biotech – BB Biotech
The recent sell-off in global stock markets has presented attractive takeover opportunities in the biotech sector, according to BB Biotech AG.
biotech
-
-
AXA expands biotech and healthcare team
AXA Investment Managers hires Peter Hughes as a healthcare equity analyst to its biotech and healthcare team.
-
Contrarian view on US equities can reap rewards – Legg Mason
Taking a contrarian view on United States equities can reap rewards according to Evan Bauman, co-lead manager of the Legg Mason ClearBridge US Aggressive Growth Fund.
